Publications

Search our bibliography using the filters on the right-hand side.

Displaying 1 through 50 of 72 publications.
Weibel D, De Luise C, Elbers R, van den Bor R, Martin I, Cid-Royo A, Plana E, Garcia de Albeniz Martinez X, Weinrib R, Yefimenko N, Poblador-Plou B, Marconi E, Barbieri E, Stona L, Swart KMA, Roy D, Hyeraci G, Bartolini C, Lupattelli A, Villalobos F, Kendrick K, Garg R, Rubino H, Eijkemans R, Sturkenboom M, Arana A. Utilisation patterns of the COVID-19 mRNA vaccine (Comirnaty®) from the VAC4EU active safety surveillance study in five European countries. Poster presented at the 39th ICPE Annual Conference; August 25, 2023. Halifax, Canada. [abstract] Pharmacoepidemiol Drug Saf. 2023 Oct 12; 32(S1):173-4. doi: 10.1002/pds.5687
Weibel D, Sturkenboom M, Eijkemans R, van den Bor R, Elbers R, Plana E, Garcia de Albeniz X, Weinrib R, Yefimenko N, Bianchini E, Stona L, Poblador-Plou B, Swart-Polinder K, Bartolini C, Hyeraci RG, Roy D, Lupattelli A, Villalobos F, Barbieri E, Garg RK, Rubino H, De Luise C, Arana A. VAC4EU active safety surveillance study of the BNT162b2 COVID-19 vaccine in five European countries: study design and first results. Poster presented at the 2022 ICPE Conference; August 30, 2022. Copenhagen, Denmark. [abstract] Pharmacoepidemiol Drug Saf. 2022 Sep 23; 31(S2):627-8. doi: 10.1002/pds.5518
Puig S, Marcoval J, Paradelo C, Azon A, Bartralot R, Bel S, Bigata X, Boada A, Campoy A, Carrera C, Curco N, Dalmau J, Ferrandiz C, Ferrerres JR, Formigon M, Gallardo F, Gonzalez A, Just M, Llistosella E, Marti RM, Nogues ME, Pedragosa R, Pujol JA, Roldan-Marin R, Sabat M, Salleras M, Smandia JA, Zaballos P, Plana Hortoneda E, Malvehy J. Melanoma incidence increases in the elderly of Catalonia but not in the younger population: effect of prevention or consequence of immigration? Acta Derm Venereol. 2015 Apr 15;95(4):422-6. doi: 10.2340/00015555-1997
Afonso ASM, Schmiedl S, Becker C, Primatesta P, Plana E, Souverin PC, Korevaar JC, Hasford J, Reynolds R, de Groot MCH, Schlienger RG, Klungel OH, Rottenkolber M. Association between inhaled long-acting beta-2-agonists and the risk of acute myocardial infarction: a methodological comparison of two databases. Poster presented at the 30th International Conference on Pharmacoepidemiology & Therapeutic Risk Management; October 2014. Taipei, China. [abstract] Pharmacoepidemiol Drug Saf. 2014 Oct; 23(S1):390-1.
Hellwig K, Koren G, Butzkueven H, Tilson H, Hernández-Diaz S, MacDonald T, Kornyeyeva E, Plana E, Lu Y, Cremer M, Amar RK, Schlosshauer R, Collins W, Geissbühler Y, Karlsson G. Cumulative data on pregnancy outcomes after exposure to fingolimod. Presented at the 29th Congress of the European Committee for Research and Treatment in Multiple Sclerosis (ECTRIMS); October 2013. Copenhagen, Denmark. Previously presented at the 18th Annual Conference of Rehabilitation in MS (RIMS).
Rottenkolber M, Voogd E, van Dijk L, Primatesta P, Becker C, Schlienger R, de Groot MCH, Plana E, Alvarez Y, Durand J, Slattery J, Afonso A, Requena G, Gil M, Huerta C, Alvarez A, de Abajo F, Hesse U, Fischer R, Hasford J, Gerlach R, Tauscher M, Reynolds R, Klungel OH, Schmiedl S. Time trends in prevalence of inhaled long-acting beta-2-adrenoceptor agonist prescribing – A comparison of seven European electronic health record databases. Poster presented at the 29th International Conference on Pharmacoepidemiology & Therapeutic Risk Management 2013; August 2013. Montreal, Canada.